Clinical Trial Update: Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients. [Phase 4]

View source ↗

Summary

Clinical trial update for astaxanthin as an adjuvant therapy in community-acquired pneumonia; phase 4, status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Astaxanthin

Snippet

Sponsor: Future University in Egypt | Conditions: Community-acquired Pneumonia | Phase 4 | Status: UNKNOWN